Connecting you to content on EBSCOhost

Works matching IS 08909091 AND DT 2022 AND VI 36 AND IP 5

Results: 8

1

Emerging Therapies for Relapsed/ Refractory Multiple Myeloma.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 330

By:

Lonial, Sagar

Publication type:

Article

2

Reducing Busy Work for the Busy Doctor.

Published in:: Oncology (08909091), 2022, v. 36, n. 5, p. 323
Publication type:: Article

3

EXPERT COMMENTARY ON THE PRODUCT PROFILE OF Dostarlimab.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 321

By:

May, Megan

Publication type:

Article

4

Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell Carcinoma.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 316

By:

Panian, Justine;
Pan, Elizabeth;
Shi, Veronica;
Hinds, Brian;
McKay, Rana R.

Publication type:

Article

5

Current Treatment of Peripheral T-cell Lymphoma.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 293

By:

Stuver, Robert;
Epstein-Peterson, Zachary D.;
Johnson, William T.;
Khan, Niloufer;
Lewis, Natasha;
Moskowitz, Alison J.;
Sauter, Craig S.;
Horwitz, Steven M.

Publication type:

Article

6

Cancer-Related Fatigue Outcome Measures in Integrative Oncology: Evidence for Practice and Research Recommendations.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 276

By:

Gentile, Danielle;
Beeler, Dori;
Wang, Xin Shelley;
Ben-Arye, Eran;
Zick, Suzanna;
Bao, Ting;
Carlson, Linda E.;
Ghelman, Ricardo;
Master, Viraj A.;
Tripathy, Debu;
Zhi, W. Iris

Publication type:

Article

7

Increasing Knowledge About Integrative Oncology May Serve to Reduce Cancer Burden.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 268

By:

Mao, Jun J.

Publication type:

Article

8

CRISPR Patent Battle: Beautiful Science, Poor Public Policy.

Published in:

Oncology (08909091), 2022, v. 36, n. 5, p. 263

By:

Hochster, Howard S.

Publication type:

Article